Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veeva Systems Inc (NY: VEEV )

177.08 +3.54 (+2.04%)
Official Closing Price Updated: 4:10 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Veeva Systems Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Cloud Stocks: Analysis Of Veeva CRM’s Split From Salesforce
Veeva’s CRM was built on the Salesforce platform, but Veeva has made sure it continued to build a parallel platform as well. Veeva Vault has been designed specifically for the life sciences value chain... 
Via Talk Markets
Here's How Much $1000 Invested In Veeva Sys 5 Years Ago Would Be Worth Today
 
Via Benzinga
Analyst Expectations for Veeva Sys's Future
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
 
Via Benzinga
Better Cloud Stock: Salesforce vs. Veeva Systems
Which CRM play is better poised for a comeback this year? 
Via The Motley Fool
Keybanc Maintains Overweight Rating for Veeva Sys: Here's What You Need To Know
 
Via Benzinga
7 Cloud Computing Stocks That Can Make You a Millionaire as Data Explodes
Investors looking to get in on a hot sector of the technology industry should consider taking a position in one of these stocks. 
Via InvestorPlace
Is Veeva Systems a Good Stock to Buy Now?
The life science industry's favorite cloud software provider recently exceeded expectations, but its forward outlook was softer than hoped. 
Via The Motley Fool
Target To Rally 20%? Here Are 10 Other Analyst Forecasts For Thursday
Bernstein raised the price target for Okta, Inc. (NASDAQ: OKTA) from $80 to $92. Bernstein analyst Peter Weed maintained a Market Perform rating. Okta shares jumped 16.2% to $83.00 in pre-market... 
Via Benzinga
Veeva Systems (VEEV) Q4 2023 Earnings Call Transcript
VEEV earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
10 Best Stocks to Buy in March 2023
These diversified growth stocks could add rocket fuel to your long-term investment portfolio. 
Via The Motley Fool
Preview: Veeva Systems's Earnings
 
Via Benzinga
Expert Ratings for Veeva Sys
 
Via Benzinga
Is Veeva Systems Stock a Buy Now?
The growth stock is rallying so far this year, but how long will that last? 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
 
Via Benzinga
A Bull Market Is Coming: 2 Exceptional Growth Stocks to Buy Now and Hold Forever
These businesses dominate their rapidly growing niche markets. 
Via The Motley Fool
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
Cannabis companies of all sizes are struggling to increase their profit margins and to make that happen, they're implementing different strategies. Lowering prices and premiumizing products are among... 
Via Benzinga
Veeva Systems Stock Is a Healthcare Gem
"There's no other competitor that does this as well as Veeva." 
Via The Motley Fool
Analyst Ratings for Veeva Sys
 
Via Benzinga
Why Did Veeva Systems Stock Fall 15% in December?
Investors were disappointed by Veeva's growth and profit forecasts. 
Via The Motley Fool
Buying These 2 Under-the-Radar Stocks for 2023 Could Be a Smart Move
Even a volatile market can be a great time to scoop up wonderful companies. 
Via The Motley Fool
Got $2,000? Here Are 3 Smart Stocks to Buy Now
These stocks are shrewd buys ahead of the next market recovery. 
Via The Motley Fool
Five Best And Worst Performing Healthcare Stocks In December 2022
Multiple factors are expected to help the healthcare industry overcome inflationary pressures. If you are looking to invest in this sector, then to help you select, here are the five best and worst... 
Via Talk Markets
2 Growth Stocks Down 35% or More to Buy and Hold in 2023 and Beyond
These companies aren't doing nearly as badly as their recent stock market performances might suggest. 
Via The Motley Fool
Why Veeva Systems Stock Flopped While the Market Popped Today
Investors aren't the only market players getting more bearish on the healthcare tech specialist. 
Via The Motley Fool
Veradigm Stock Showing Improving Market Leadership; Earns 82 RS Rating
On Monday, medical software Veradigm stock had its Relative Strength (RS) Rating upgraded to 82, up from 79 a day earlier. 
Via Investor's Business Daily
How to Invest $15,000 Today If You Had to Start From Scratch
The stock market is packed with more opportunities than ever for first-time investors. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.